Literature DB >> 28188009

Heart Transplant and Mechanical Circulatory Support in Patients With Advanced Heart Failure.

Cristina Sánchez-Enrique1, Ulrich P Jorde2, José González-Costello3.   

Abstract

Patients with advanced heart failure have a poor prognosis and heart transplant is still the best treatment option. However, the scarcity of donors, long waiting times, and an increasing number of unstable patients have favored the development of mechanical circulatory support. This review summarizes the indications for heart transplant, candidate evaluation, current immunosuppression strategies, the evaluation and treatment of rejection, infectious prophylaxis, and short and long-term outcomes. Regarding mechanical circulatory support, we distinguish between short- and long-term support and the distinct strategies that can be used: bridge to decision, recovery, candidacy, transplant, and destination therapy. We then discuss indications, risk assessment, management of complications, especially with long-term support, and outcomes. Finally, we discuss future challenges and how the widespread use of long-term support for patients with advanced heart failure will only be viable if their complications and costs are reduced.
Copyright © 2017 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Advanced heart failure; Heart transplant; Insuficiencia cardiaca avanzada; Mechanical circulatory support; Soporte circulatorio mecánico; Trasplante cardiaco

Mesh:

Year:  2017        PMID: 28188009     DOI: 10.1016/j.rec.2016.12.036

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  2 in total

1.  Achalasia as an Unusual Cause of Acute Cellular Rejection of a Transplanted Heart.

Authors:  Amanda Fernandes; Crystal Lihong Yan; Phillip Ruiz; Nina Thakkar Rivera
Journal:  Case Rep Cardiol       Date:  2022-09-28

2.  Different Routes of Proton Pumps Inhibitors Co-Administration have Significant Impact on Mycophenolate Acid (MPA) Serum Levels in Heart Transplant Recipients.

Authors:  Tomasz Urbanowicz; Ewa Straburzyńska-Migaj; Veronica Casadei; Michał Bociański; Marek Jemielity
Journal:  Ann Transplant       Date:  2020-01-24       Impact factor: 1.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.